09.02.2015 Views

Stability of Drugs and Dosage Forms Sumie Yoshioka

Stability of Drugs and Dosage Forms Sumie Yoshioka

Stability of Drugs and Dosage Forms Sumie Yoshioka

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

44 Chapter 2 • Chemical <strong>Stability</strong> <strong>of</strong> Drug Substances<br />

Scheme 68. Consecutive loss <strong>of</strong> carbamate groups in carmethizole (NSC-602668). The reactivity <strong>of</strong> one<br />

carbamate group is greater than that <strong>of</strong> the other. (Reproduced from Ref. 46 with permission.)<br />

(2.30)<br />

A good example <strong>of</strong> consecutive reactions is the degradation <strong>of</strong> carmethizole (NSC-602668), an<br />

experimental cytotoxic agent (Scheme 68). 44 The hydrolysis <strong>of</strong> hydrocortisone hemisuccinate<br />

(Fig. 11) 30 <strong>and</strong> alkaline epimerization followed by hydrolysis <strong>of</strong> etoposide (Fig. 12) 156,157 fit this<br />

mathematical model even though their degradation pathways are more complex.<br />

2.2.3.1.g.<br />

Pseudo-First-Order Reversible <strong>and</strong> Consecutive Reactions<br />

When drug D is reversibly converted to P 1 , which is reversibly converted to P 2 by<br />

apparent first-order kinetics, Equations (2.31) <strong>and</strong> (2.32) represent the rate <strong>and</strong> integrated<br />

expressions, respectively.<br />

Figure 11. Time course <strong>of</strong> hydrolysis <strong>of</strong> hydrocortisone hemisuccinate (pH 6.9, 70°C). (Reproduced from Ref.<br />

30 with permission.)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!